SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (21895)6/5/1998 1:42:00 PM
From: Machaon  Read Replies (2) of 32384
 
<< The approach allows for screening of anatgonists as well as agonists and the compounds can be made and modified very cheaply. Thus, the various established Biotech products are fair targets, as are many of the current products under development. >>

That was quite an interesting and complex note to Andrew. I pulled out one, of several paragraphs, for which I would appreciate it, if you could explain a little more. Why are established Biotech products "fair targets"?

Thanks, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext